Here, we reported significantly reduced total antioxidant capacity and increased activity of glutathione peroxidase, glutathione reductase and glutathione S-transferase in the area of the myocardial infarction, regardless of the drugs used. The gene discussed is HPGDS; the disease is myocardial infarction.